The PIXI platform - Trace Protein Marker Detector $r $n reduces sample size, shortens detection time, and does not require a large number of manual labor to perform ELISA, greatly improving productivity.
PIXI platform-Trace protein biomarker detector
Reducing sample size, shortening detection time, and eliminating the need for a large number of personnel to perform physical labor for ELISA greatly improve productivity.
Trace protein biomarker detectorMicrodetermination can solve the quantitative bottleneck of protein targets in precious samples
Drug discovery pipeline
Basic research
Target-based approach
Cell-based approach
Discovery/Translation
Screening
Lead optimization
Preclinical
Development
Phase I
Phase II
Phase III
Implementation
Registration
Manufacturing
Supplementary information
More than 100 million mice are used for research and development in the United States every year
The surge of biologics drives proteomics testing
A single laboratory may measure 60000 samples per year
Users hope to obtain more data from a limited sample
Biological agents and synthetic biomanufacturing
Monoclonal antibody amplification and production
Recombinant protein library screening (2000 24 targets)
Users hope to minimize the use of testing items in testing to the greatest extent possible